Home / Learn / Resource Detail

Highlights from the ACCC Working Summit: Biomarker Testing – Solutions for EHR Integration — [MINI PODCAST] EP 136

November 10, 2023

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!

Health technology performance and integration of electronic health record (EHR) systems—the creation of interfaces between EHRs and reference labs performing biomarker testing— have become critical factors in conducting efficient and equitable biomarker testing at cancer programs nationwide. At ACCC’s 40th Annual National Oncology Conference, an exclusive EHR Working Summit was held to understand barriers to integrating biomarker testing into EHR systems and explore effective practices/workaround solutions to facilitate timely and comprehensive biomarker testing.

In this episode, CANCER BUZZ speaks with Karen Huelsman, MS, LGC, precision oncology lead and genetic counselor at TriHealth Cancer and Blood Institute, who also serves on ACCC’s EHR Integration program Advisory Committee, about key takeaways and insights from the Working Summit.


Karen Huelsman

Karen Huelsman, MS, LGC
Precision Oncology Lead, Genetic Counselor
TriHealth Cancer and Blood Institute
Cincinnati, Ohio

“Some of the key barriers include limited staffing on information systems and technical teams—that’s the number one ingredient—[also] funding is an important element, having enough FTEs [full-time employees] to create a team, having knowledgeable data engineers and project coordinators…and trying to include some level of clinical input for any new integration implementation team is really important, and those are not always available…” – Karen Huelsman, MS, LGC

This episode was developed in connection with the ACCC education program EHR Integration: Effective Practices to Facilitate Timely and Comprehensive Biomarker Testing. This educational program is made possible with support by AstraZeneca and Genentech.

Additional Reading/Sources

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.